Published in Korean J Parasitol on March 01, 2007
Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo. Malar J (2011) 1.22
Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2. Malar J (2010) 1.12
Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Malar J (2010) 1.10
Genetic structure of Plasmodium vivax and Plasmodium falciparum in the Bannu district of Pakistan. Malar J (2010) 0.95
Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras. Malar J (2012) 0.94
Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from children in South of Benin. Parasite (2013) 0.84
Molecular cloning and characterisation of the RESA gene, a marker of genetic diversity of Plasmodium falciparum. Mol Biol Rep (2009) 0.75
Plasmodium falciparum merozoite surface protein 1 block 2 gene polymorphism in field isolates along the slope of mount Cameroon: a cross - sectional study. BMC Infect Dis (2015) 0.75
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg (2000) 7.93
Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun (1995) 2.48
Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ (1995) 2.00
No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg (1998) 1.96
Current status of malaria and potential for control. Clin Microbiol Rev (2001) 1.92
Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda. Trop Med Int Health (2001) 1.61
Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am J Trop Med Hyg (1996) 1.60
Current views on the population structure of plasmodium falciparum: Implications for control. Parasitol Today (1997) 1.44
Antigenic diversity and immune evasion by malaria parasites. Clin Diagn Lab Immunol (2004) 1.39
Knowledge, perceptions and prevention of malaria among women in Sistan va Baluchestan, Islamic Republic of Iran. East Mediterr Health J (2003) 1.35
Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp Parasitol (2003) 1.26
Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Malar J (2003) 1.15
Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health (2005) 1.14
Population structure of Plasmodium falciparum isolates during an epidemic in southern Mauritania. Trop Med Int Health (2001) 1.03
Genetic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum in different malaria-endemic localities. Am J Trop Med Hyg (2004) 1.01
A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology (1999) 1.00
Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran. J Trop Med Hyg (1993) 0.96
Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann Trop Med Parasitol (2003) 0.92
Plasmodium falciparum: a comparative analysis of the genetic diversity in malaria-mesoendemic areas of Brazil and Madagascar. Parasitol Res (2000) 0.89
Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran? Trans R Soc Trop Med Hyg (2002) 0.87
Malaria vaccines: where are we and where are we going? Lancet Infect Dis (2002) 0.81
Malaria vaccines. Br Med Bull (2002) 0.81
Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis (2007) 2.92
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Trop Med Int Health (2004) 1.75
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar J (2007) 1.69
Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut (2006) 1.60
Expert opinion on vaccination of travelers against Japanese encephalitis. J Travel Med (2009) 1.49
Malarone treatment failure not associated with previously described mutations in the cytochrome b gene. Malar J (2004) 1.23
CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. PLoS Negl Trop Dis (2010) 1.14
Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study. Malar J (2012) 1.10
Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health (2005) 1.07
Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR. Trop Med Int Health (2003) 1.07
Rapid detection of human Leishmania infantum infection: a comparative field study using the fast agglutination screening test and the direct agglutination test. Travel Med Infect Dis (2010) 1.06
Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos. Trop Med Int Health (2003) 1.01
Dengue antibody prevalence in German travelers. Emerg Infect Dis (2005) 0.96
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51. Vaccine (2011) 0.94
Epidemiological characterization of Plasmodium falciparum in the Republic of Cabo Verde: implications for potential large-scale re-emergence of malaria. Malar J (2006) 0.94
Direct Effect of Two Naphthalene-Sulfonyl-Indole Compounds on Toxoplasma gondii Tachyzoite. J Parasitol Res (2013) 0.94
Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malar J (2003) 0.92
Short communication: point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Colombia. Trop Med Int Health (2003) 0.92
Preparation and evaluation of a glycerol-preserved direct agglutination antigen for long-term preservation: a comparative study of the detection of anti-Leishmania infantum antibodies in human and dog. Asian Pac J Trop Med (2012) 0.91
Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. Am J Trop Med Hyg (2002) 0.90
Genotypes and in vivo resistance of Plasmodium falciparum isolates in an endemic region of Iran. Parasitol Res (2006) 0.88
Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana. Trop Med Int Health (2004) 0.88
Distribution of the two forms of Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene in Lao PDR. Malar J (2003) 0.87
Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran? Trans R Soc Trop Med Hyg (2002) 0.87
Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. Korean J Parasitol (2012) 0.86
Variability in malaria prophylaxis prescribing across Europe: a Delphi method analysis. J Travel Med (2008) 0.86
Delivery of medical care for migrants in Germany: delay of diagnosis and treatment. J Travel Med (2006) 0.86
Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med (2005) 0.85
Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults. J Travel Med (2014) 0.84
Dengue in travelers: a review. J Travel Med (2005) 0.83
Clinical features and pitfalls in the laboratory diagnosis of dengue in travellers. BMC Infect Dis (2006) 0.82
Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran. Exp Parasitol (2012) 0.80
Efficacy of a travelers' diarrhea vaccine system in travelers to India. J Travel Med (2013) 0.79
Leptospirosis in travelers returning from the Dominican Republic. J Travel Med (2003) 0.79
Travelers' preferences for the treatment and prevention of acute diarrhea. J Travel Med (2009) 0.79
Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum. Exp Parasitol (2012) 0.78
Malaria chemoprophylaxis recommendations for immigrants to Europe, visiting relatives and friends--a Delphi method study. Malar J (2011) 0.78
Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor. J Travel Med (2007) 0.78
The possible association between Toxoplasma gondii infection and risk of anxiety and cognitive disorders in BALB/c mice. Pathog Glob Health (2015) 0.78
Genetic polymorphism at the C-terminal domain (region III) of knob-associated histidine-rich protein (KAHRP) of Plasmodium falciparum in isolates from Iran. Parasitol Res (2011) 0.78
Comparing the cognitive, personality and moral characteristics of high school and graduate medical entrants to the Tehran University of Medical Sciences in Iran. Med Teach (2013) 0.78
Prophylaxis failure due to probable mefloquine resistant P falciparum from Tanzania. Acta Trop (2003) 0.78
Malaria clusters among illegal Chinese immigrants to Europe through Africa. Emerg Infect Dis (2003) 0.77
Detection of malaria infection in blood transfusion: a comparative study among real-time PCR, rapid diagnostic test and microscopy: sensitivity of Malaria detection methods in blood transfusion. Parasitol Res (2011) 0.77
[Molecular epidemiological surveillance of markers for antimalarial drugs in Plasmodium falciparum isolates imported to Barcelona, Spain]. Med Clin (Barc) (2005) 0.77
Real-time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii Tehran strain. Korean J Parasitol (2012) 0.77
Detection of Toxoplasma gondii from sera and urine of experimentally infected mice by PCR. Pak J Biol Sci (2007) 0.77
[Ill tropical traveler returning home]. Med Klin (Munich) (2005) 0.75
Transparency in publishing. J Travel Med (2004) 0.75
Tolerability of multiple vaccinations in travel medicine. J Travel Med (2003) 0.75
Images in clinical medicine. Loiasis. N Engl J Med (2006) 0.75
Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults. J Travel Med (2014) 0.75
["The world epidemic situation changes." Interview by Stephanie Hügler]. Dtsch Med Wochenschr (2009) 0.75